Uncovering Tumour Heterogeneity through PKR and nc886 Analysis in Metastatic Colon Cancer Patients Treated with 5-FU-Based Chemotherapy

Autor: María Ángel García, Alberto Mesa, Elisa L. J. Moya, Igor Zwir, Luis Javier Martinez-Gonzalez, Gabriel Lopez-Ordoño, María Belén Ortega-García, Eduardo Redondo-Cerezo, Javier Ángel García, Juan A. Marchal, Macarena Perán, Javier Luis Lopez-Hidalgo, V. Conde, Gema Jiménez, Coral del Val, Beatriz Rueda

Publikováno v: Cancers
Volume 12
Issue 2
Cancers, Vol 12, Iss 2, p 379 (2020)
Digibug. Repositorio Institucional de la Universidad de Granada
instname

Colorectal cancer treatment has advanced over the past decade. The drug 5-fluorouracil is still used with a wide percentage of patients who do not respond. Therefore, a challenge is the identification of predictive biomarkers. The protein kinase R (P

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::96ca1fa23bb9066e4cc8c9e2e62c57bb